The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents.
暂无分享，去创建一个
Narendra Kumar Patel | Y. Liu | T. Mak | N. Chirgadze | P. Sampson | O. Plotnikova | F. Ban | D. Awrey | W. Qiu | I. Beletskaya | M. Bray | M. Feher | R. Kiarash | J. Mason | Xin Wei | G. Fletcher | L. Edwards | Sze‐Wan Li | R. Hodgson | H. Pauls | Bryan T. Forrest | Radoslaw S. Laufer | Grace Ng | Yunhui Lang | D. Lin | Yi Che | Guodong Mao | Brian Madeira | G. Mao | Sze-Wan Li | Fuqiang Ban